ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
Dow Jones
39.118,86
-0,12%
Euro vs US Dollar
1,07205
0,00%
Bitcoin
60.648,18
0,56%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Legacy Healthcare Properties (LRP)

  7. Legacy Healthcare Properties (LRP) News

LRP

Legacy Healthcare Properties (LRP)

Legacy Healthcare Properties
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:LRP
DatumZeitQuelleÜberschriftSymbolFirma
13/04/201121h30Edgar (US Regulatory)Withdrawal of Registration Statement (RW)NYSE:LRPLegacy Healthcare Properties
05/10/201012h21Edgar (US Regulatory)Securities Registration: Real Estate Company (S-11/A)NYSE:LRPLegacy Healthcare Properties
16/09/201023h30Edgar (US Regulatory)Securities Registration: Real Estate Company (S-11/A)NYSE:LRPLegacy Healthcare Properties
21/07/200821h24PR Newswire (US)/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./NYSE:LRP
21/07/200813h30PR Newswire (US)Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008NYSE:LRP
16/07/200814h12PR Newswire (US)Lorus Therapeutics Receives $600 Thousand From Escrow AccountNYSE:LRP
09/07/200814h00PR Newswire (US)Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development ProgramNYSE:LRP
02/07/200815h00PR Newswire (US)Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination withNYSE:LRP
23/06/200813h30PR Newswire (US)Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for tNYSE:LRP
06/05/200822h22PR Newswire (US)AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing StandardsNYSE:LRP
05/05/200813h30PR Newswire (US)Lorus Therapeutics Strengthens Its Senior Management Team Through Internal PromotionsNYSE:LRP
22/04/200814h30PR Newswire (US)Lorus initiates development program exploring novel route of administration for LOR-2040NYSE:LRP
16/04/200814h30PR Newswire (US)Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040NYSE:LRP
09/04/200804h04PR Newswire (US)Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)NYSE:LRP
23/01/200800h17PR Newswire (US)Lorus Therapeutics Appoints Peter Korth as Chief Financial OfficerNYSE:LRP
06/11/200713h30PR Newswire (US)Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare ConferenceNYSE:LRP
20/09/200704h23PR Newswire (US)Lorus Therapeutics announces election of three new Directors and appoints a new ChairmanNYSE:LRP
29/08/200714h30PR Newswire (US)Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid LeukemiaNYSE:LRP
24/07/200700h48PR Newswire (US)Lorus Therapeutics Announces the Appointment of a New Member of the Board of DirectorsNYSE:LRP
11/07/200702h04PR Newswire (US)Lorus Therapeutics completes reorganization resulting in non dilutive financingNYSE:LRP
05/07/200723h39PR Newswire (US)Lorus Therapeutics announces revised closing date for proposed plan of arrangementNYSE:LRP
19/06/200715h30PR Newswire (US)Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndromeNYSE:LRP
14/05/200715h30PR Newswire (US)Lorus announces presentation of corporate overview at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare ConferenceNYSE:LRP
02/05/200704h59PR Newswire (US)Lorus Therapeutics announces reorganization resulting in approximately $7,800,000 of non-dilutive financingNYSE:LRP
19/04/200715h30PR Newswire (US)Lorus Therapeutics reports third quarter results for fiscal year 2007NYSE:LRP
17/04/200715h30PR Newswire (US)Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer ConfeNYSE:LRP
01/03/200714h00PR Newswire (US)Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer TherapyNYSE:LRP
29/12/200613h00PR Newswire (US)Lorus Therapeutics reports second quarter results for fiscal year 2007NYSE:LRP
06/11/200616h04PR Newswire (US)Lorus announces presentation of corporate overview at the Rodman and Renshaw 8th Annual Healthcare ConferenceNYSE:LRP
01/11/200613h00PR Newswire (US)Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemiaNYSE:LRP
 Showing the most relevant articles for your search:NYSE:LRP

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
TG
LHA
Deutsche Lufthansa
NASDAQ
AMZN
Amazon.com
DBI
MDAX
MDAX
NASDAQ
AAPL
Apple
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
FX
EURUSD
Euro vs US Dollar
TG
TUI1
Tui
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten